Pacira Pharma (NASDAQ: PCRX) reported Q3 EPS of $0.48, $0.15 better than the analyst estimate of $0.33. Revenue for the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE